您的位置: 首页 > 农业专利 > 详情页

Intrapulmonary administration of polynucleotide agonists of toll-like receptor-9 for the treatment of lung cancer
专利权人:
Dynavax Technologies Corporation
发明人:
GUIDUCCI, Cristiana,COFFMAN, Robert L.
申请号:
DK16727089
公开号:
DK3302502T3
申请日:
2016.05.23
申请国别(地区):
DK
年份:
2019
代理人:
摘要:
The present disclosure relates to methods for treating cancer by intrapulmonary administration of a polynucleotide Toll-like receptor 9 agonist. The methods of the present disclosure are suitable for treating primary cancer of the lung, as well as metastatic cancer to the lung and extra pulmonary cancers thereof. Additionally, the present disclosure provides polynucleotide Toll-like receptor 9 agonists with immune stimulatory and toxicity profiles suitable for intrapulmonary administration.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充